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Method for Angiographically Guided Fine-Needle
Diathermy in the Treatment of Corneal Neovascularization
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Colin E. Willoughby, MD, FRCOphth,*‡ and Stephen B. Kaye, MD, FRCS, FRCOphth*‡
Purpose: To describe a method to assess corneal neovascular
(CoNV) complexes and identify feeder vessels for selective arterial
ﬁne-needle diathermy (FND).
Methods: In patients with CoNV, color photography and corneal
indocyanine green angiography (ICGA) and ﬂuorescein angiography
are performed. After injection of indocyanine green and sodium
ﬂuorescein dye, videography and single-frame images of the region
of interest are recorded. Videography is used to measure the time to
leakage to assess vessel maturity to guide medical treatment and to
discern afferent from efferent vessels. Single-frame images are then
selected to locate the number of afferent vessels for surgery, which
are selectively cut with a 25-gauge marked needle for the application
of FND.
Results: Angiography using ﬂuorescein and indocyanine green
allows the characterization of CoNV based on assessment of both
morphologic (ICGA) and functional (ﬂuorescein angiography)
parameters. The time to leakage of ﬂuorescein dye provides
important functional information on vessel maturity and helps
discern whether medical treatment should be followed before
surgical. ICGA allows the identiﬁcation and delineation of afferent
feeder vessels even in the presence of corneal opacities affecting
biomicroscopic visibility. Colocalizing the afferent vessel to a visible
venous landmark or branch is helpful for placement of the incision and
application of FND. Using the described approach, angiographically
identiﬁed feeder vessels can be selectively treated by FND
with minimal thermal energy applied to the corneoscleral limbus.
Conclusions: The described method for angiographically guided
assessment of CoNV is a useful approach for guiding the medical
and surgical treatment of CoNV.
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(Cornea 2016;0:1–4)
Corneal neovascularization (CoNV) is a global healthproblem. It is estimated that 1.4 million people per year
develop CoNV, 12% of whom suffer subsequent loss of
vision.1 Additionally, vascularization of the recipient cornea
before transplantation is a leading cause for earlier and more
marked graft rejection.2
Several medical and surgical treatment approaches for the
management of CoNV have been investigated with varying
degrees of clinical success. VEGF plays a prominent role in
corneal angiogenesis, and selective inhibitors of VEGF have
been applied successfully in treating active CoNV, targeting
predominantly immature vessels.3 Although surgical treatment
such as ﬁne-needle diathermy (FND) has become popular for
the treatment of more established vessels in CoNV,4 potential
adverse effects need to be considered. These include potential
damage to the corneal endothelium and the limbal epithelial
stem cell niche and, particularly when not applied selectively,
may lead to inﬂammation, scarring, and varying degrees of
irregular corneal astigmatism. Until recently, the most widely
used method was described by Faraj et al,5 using unipolar
diathermy applied to all areas of visible blood vessels through
a 3/8 circle-side–cutting, single-armed needle attached to a 10-0
monoﬁlament nylon suture. This technique, however, is
associated with extensive application of thermal energy to all
corneal structures including the deep peripheral corneal stroma,
potentially damaging the corneal endothelium beneath and
surrounding the coagulation site similar to that observed after
radial thermokeratoplasty. Additional adverse effects include
the modiﬁcation of the corneal curvature and collagen shrinkage
with potential damage to adjacent corneal stroma.6–9 Long-term
effects of diathermy to the cornea and the corneoscleral limbal
stem cell niche remain to be clariﬁed. The process of corneal
diathermy itself may be a stimulus for further CoNV by
secondary release of proangiogenic factors.10 It would, there-
fore, seem reasonable to try and minimize the application of
FND to the cornea. We recently reported the results of selective
FND to the afferent vessel(s)11,12 and describe below the
protocol for this angiography-guided treatment approach.
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PROTOCOL
Imaging Section (Color Photography,
Fluorescein Angiography, and Indocyanine
Green Angiography)
Color images are captured using a slit-lamp–mounted
digital system (SL-D Digital Slit Lamp; Topcon, Tokyo,
Japan) at 10 to 25-power magniﬁcation. An HRA2 Scanning
Laser Ophthalmoscope (Heidelberg Engineering, Heidelberg,
Germany) with a 20° imaging lens set at 34 diopters is used
for indocyanine green angiography (ICGA) and ﬂuorescein
angiography as previously described.13,14 It is important to
note that in the healthy state, the vasculature surrounding the
peripheral cornea and limbus ﬁlls in a distinctive pattern with
the inferior (I) quadrant ﬁlling ﬁrst, followed by the superior
(S), nasal (N), and ﬁnally temporal (T) quadrants (the ISNT
rule).13 In addition, the age and cardiovascular status are
important considerations in determining the time elapsed
before commencement of the video recording for the
appearance of dye in the afferent vessels. In a young person,
dye would be expected to be seen approximately 10 seconds
after injection, whereas in an elderly person the dye may not
appear until after 25 seconds. After injection of 5 mL of ICG
dye (5 mg/mL; Pulsion Medical Systems, Feldkirchen,
Germany), videography is performed for 25 seconds (see
Video, Supplemental Digital Content 1, http://links.lww.com/
ICO/A409). ICGA provides excellent vessel resolution par-
ticularly in areas of corneal scarring, inﬁltrate, or edema
(Figs. 1C, F). Single-frame ICGA images of the region of
interest of the cornea and limbus capturing corneal blood
vessel ﬂuorescence are taken every 3 to 5 seconds for
3 minutes, followed by late images at 5 and 10 minutes. An
intravenous injection of 3 mL of 20% sodium ﬂuorescein
(Martindale Pharmaceuticals, Essex, United Kingdom) is then
given and the videography repeated. Fluorescein angiography
provides important information on time to leakage, which is
important to assess vessel maturing and late reuptake by
lymphatics (Figs. 1B, E). During the acquisition of single-
frame ICGA and Fluorescein angiography images, high-
resolution mode with eye tracking, automatic, real-time
software is used. Single-frame stereoscopic images can
provide useful information regarding the location and depth
of the vessel(s).
Image Analysis
Video analysis allows the identiﬁcation of the location
and number of afferent vessels crossing the peripheral cornea
and limbus and measurement of the time to leakage of
ﬂuorescein. The extent of leakage aids in the clinical decision
between medical and surgical treatment, time and extent of
leakage being an indirect indicator of vessels maturity. Vessels
with early and intense leakage may still be responsive to
topical steroid treatment or subconjunctival injection of VEGF
inhibitors, potentially without the need for FND.15 The
identiﬁed afferent vessels are colocalized on color photographs
using visible landmarks such as a vessel branch to guide
selective arteriolar FND.9,16,17 Semiautomated programs using
Matlab R14 (The MathWorks Inc, Natick, MA) are helpful in
analyzing vessel parameters such as area of CoNV and vessel
length, diameter, branch points, and tortuosity, which are
useful information for monitoring outcome.13,14 It is important
to note that the afferent (arterial) vessels usually lie below and
deeper in the corneal stroma to the associated venules, are often
not visible on color images, and may not be easily discernible
on slit-lamp biomicroscopy. On colocalizing the afferent vessel
to a visible larger venule, for example, the distance from the
venous landmark or branch allows the surgeon to place a mark
as described below.
Fine-Needle Diathermy
Afferent and efferent vessels are identiﬁed on videog-
raphy. The former are labeled on a representative angio-
graphic image and a corresponding color photograph (Fig. 1).
The annotated images are used as a reference to mark the
afferent vessel(s) with an inked needle. Using slit-lamp
biomicroscopy, a partial-thickness incision is made under
topical anesthesia, using a 25-gauge needle on a 1-mL syringe
into the posterior stroma over the identiﬁed afferent vessel(s)
either at the limbus or at the level of marginal corneal arcades.
A 25-gauge needle is preferred to a blade as it causes less
obscuration of structures and can be more easily advanced at
the slip lamp under direct vision to the deep stromal feeder
vessels without necessarily causing bleeding from superﬁcial
venous vessels. Afferent vessels may be hard to distinguish
despite their known location, because they are of thinner
caliber and the fast intravascular ﬂow may not allow the
distinction of cell trafﬁc direction. Therefore, indirect illumi-
nation is used to obtain optimal conditions for the identiﬁca-
tion of these vessel characteristics. If the afferent vessel is
transected, an interruption of red blood cell trafﬁc becomes
evident in all the visible vessels, which are mainly the efferent
vessels (veins). Under the operating microscope, an Ellman
MH-EL-A2D ﬁne-wire electrolysis needle is then applied into
the incision. Energy is delivered using a unipolar approach by
a Surgitron Dual RF machine (Ellman International Inc,
Oceanside, NY) at the lowest setting (1 joule/s) until a visible
blanching of the cornea around the afferent vessel is seen and
segmentation of the blood ﬂow is noticed in the larger efferent
vessels if not already present. Patients receive prednisolone
1% eye drops 4 times a day for 4 weeks and an antimicrobial
4 times a day for 1 week.
DISCUSSION
Slit-lamp assessment of CoNV, although essential,
needs to be complemented by angiography, as only the latter
is able to reproducibly provide information to assess the
extent and activity to ultimately guide the treatment.14 Tissue
cauterization such as FND is not without risk and should be
kept to a minimum. In addition, the long-term consequences
of FND on limbal epithelial stem cell function and local
endothelial cell survival are not yet fully understood. Corneal
diathermy itself may be a stimulus for further CoNV by
secondary release of proangiogenic factors.10 Feldman et al6
showed that radial thermokeratoplasty caused damage to the
corneal endothelium beneath and surrounding the coagulation
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site. The corneal heating also modiﬁes corneal curvature and
may lead to irregular astigmatism.8 In particular, collagen
shrinkage with potential damage to adjacent corneal stroma
has been reported.8 Nonselective application will increase
inﬂammation, which may itself prejudice subsequent corneal
transplant survival. Therefore, the amount of tissue cauter-
ization should be minimized. This is of particular importance
if FND is performed for preconditioning a recipient bed for
a future corneal graft.
The described cut-down technique is preferred over the
use of a 10-0 needle because the created cut allows
veriﬁcation of blood ﬂow interruption before actual dia-
thermy. Additionally, the use of a syringe at the slit lamp
allows better depth perception, ﬂow observation, and cut
orientation compared with a surgical microscope.
Cursiefen et al reported that arterioles tend to comprise
less than 1% of the vessel area in CoNV, making them
a feasible target in the surgical treatment of CoNV.18 Biomicro-
scopic distinction of afferent and efferent vessels can be very
challenging even when aided by the patient’s pulse, and the
visible area of pathologic vessels on slit-lamp examination does
not reﬂect the true extent of CoNV.16 Corneal angiography
enables quantiﬁcation of CoNV, vessel leakage, and identiﬁca-
tion of afferent or feeder vessels for selective treatment, thereby
lessening the risks associated with this type of treatment.12,13
Although the efﬁcacy of FND in the treatment of corneal
hematic vessels is evident, its effect on corneal lymphatic or
plasma vessels in CoNV as recently shown by our group
remains to be investigated.12,16,17 Optical coherence tomography
(OCT) angiography may offer an additional complimentary
approach, but at present, it is not able to distinguish between
afferent and efferent vessels.19–21 Although OCT angiography is
likely to be a very useful adjunct, the current methods are
limited in resolution to an axial and lateral resolution of
approximately 5 to 8 mm and 20 to 20 mm22 so that components
of small vessels such as capillary loops may not be discernible.
In addition, OCT relies on red blood cell movement23–25 and is
therefore dependent and inﬂuenced by cell number and velocity
and22 is therefore not sensitive to acellular ﬂow, in particular
leakage. The latter is of particular importance as limiting initial
FIGURE 1. Graphic illustration of the preparation for angiography-guided selective arteriolar FND of CoNV. A, Arterial phase
(24 seconds) of ICGA showing the afferent feeder vessel of CoNV (arrow). B, Venous phase (21 seconds) of ICGA showing the
efferent vessels of CoNV (arrow). C, Color photograph of CoNV to identify afferent vessels from comparative analysis with
angiographic studies. D–F, In a different patient, the afferent vessel is cut with an ink-marked 25-gauge needle for subsequent
selective arteriolar FND.
Cornea  Volume 0, Number 0, Month 2016 Angio-Guided Fine-Needle Diathermy
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 3
Copyright  2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
treatment to the application of antiangiogenic factors such as
VEGF inhibitors may be the better choice if less mature or
immature vessels predominate.3
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